A PROTOCOL TO ALLOW TREATMENT WITH ICL670 FOR PATIENTS WITH OR AT RISK OF LIFE-THREATENING COMPLICATIONS OF TRANSFUSIONAL IRON OVERLOAD WHO ARE UNABLE TO TOLERATE OTHER IRON CHELATORS BECAUSE OF DOCUMENTED SEVERE TOXICITY: